A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less¶
Hammer. (1997). A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Antimicrobial Resistance Selection
- The response, from the mid-1990s, was highly active antiretroviral therapy — combining three drugs at once, drawn from at least two classes (typically two nucleoside analogues plus a protease inhibitor)
This sourceThe ACTG 320 randomized trial showing that adding the protease inhibitor indinavir to two nucleoside analogues slowed HIV progression and reduced mortality.
Supported in partVerified against the source
- The response, from the mid-1990s, was highly active antiretroviral therapy — combining three drugs at once, drawn from at least two classes (typically two nucleoside analogues plus a protease inhibitor)
Verification¶
Does it exist? Not checked yet. This work's DOI is recorded above but has not been resolved against an external catalogue, so nothing here confirms the work exists.
Does it back the claim? Read against the text for 1 of 1 citation: 1 supported in part. Each verdict is shown under its citation below, with what in the work backs the sentence.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:3b4f30d78a02 · see in the full table